Evidence map›Paper›PMID 33429366›Full record

ArticleAging2021

Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.

Long Chen, Yue Liu, Jiamin Wu, Chao Deng, Jianjun Tan, Huawen Liu, Li Zhong

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Long ChenBioengineering Institute of Chongqing University, Chongqing, China.
Yue LiuBioengineering Institute of Chongqing University, Chongqing, China.
Jiamin WuChongqing Mix Biotechnology Co., Ltb, Chongqing, China.
Chao DengThree Gorges Central Hospital, Wanzhou, Chongqing, China.
Jianjun TanThree Gorges Central Hospital, Wanzhou, Chongqing, China.
Huawen LiuThree Gorges Central Hospital, Wanzhou, Chongqing, China.
Li ZhongBioengineering Institute of Chongqing University, Chongqing, China.
Chongqing University · CNChongqing Three Gorges Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both lung adenocarcinoma and coronavirus disease 2019 would cause pulmonary inflammation. Angiotensin-converting enzyme 2, the functional receptor of SARS-CoV-2, also plays a key role in lung adenocarcinoma. To study the risk of SARS-CoV-2 infection in lung adenocarcinoma patients, mRNA and microRNA profiles were obtained from The Cancer Genome Atlas and Gene Expression Omnibus followed by bioinformatics analysis. A network which regards angiotensin-converting enzyme 2 as the center was structured. In addition, via immunological analysis to explore the essential mechanism of SARS-CoV-2 susceptibility in lung adenocarcinoma. Compared with normal tissue, angiotensin-converting enzyme 2 was increased in lung adenocarcinoma patients. Furthermore, a total of 7 correlated differently expressed mRNAs (ACE2, CXCL9, MMP12, IL6, AZU1, FCN3, HYAL1 and IRAK3) and 5 correlated differently expressed microRNAs (miR-125b-5p, miR-9-5p, miR-130b-5p, miR-381-3p and miR-421) were screened. Interestingly, the most frequent toll-like receptor signaling pathway was enriched by mRNA (interlukin 6) and miRNA (miR-125b-5p) sets simultaneously. In conclusion, it was assumed that miR-125b-5p-ACE2-IL6 axis could alter the risk of SARS-CoV-2 infection in lung adenocarcinoma patients.

Indexed as

TranscriptomeAdenocarcinoma of LungAngiotensin-Converting Enzyme 2Computational BiologyCOVID-19HumansInterleukin-6Lung NeoplasmsMicroRNAsRisk FactorsSARS-CoV-2Angiotensin-Converting Enzyme 2IL6 protein, humanInterleukin-6MicroRNAsMIRN125 microRNA, humanACE2COVID-19IL6lung adenocarcinomamiR-125b-5pSARS-CoV-2

Identifiers

PMID33429366
PMCPMC7880402
OpenAlexW3008931988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.